Cefepime: Difference between revisions
Jump to navigation
Jump to search
imported>David E. Volk m (New page: {{subpages}}) |
imported>David E. Volk mNo edit summary |
||
| Line 1: | Line 1: | ||
{{subpages}} | {{subpages}} | ||
{{Chem infobox | |||
|align=right | |||
|image=[[Image:Cefepime.jpg|center|thumb|300px]] | |||
|width=300px | |||
|molname=cefepime | |||
|synonyms= | |||
|molformula= C<sub>19</sub>H<sub>24</sub>N<sub>6</sub>O<sub>5</sub>S<sub>2</sub> | |||
|molmass=480.5611 g/mol | |||
|uses=antibiotic drug | |||
|properties=beta-lactam | |||
|hazards=see drug interactions | |||
|iupac= see chemistry section | |||
|casnumber=88040-23-7 | |||
}} | |||
'''Cefepime''' is a fourth-generation [[cephalosporin]] [[antibiotic]] developed in 1994. It has more activity than third-generation cephalosporins against Gram-postive and Gram-negative bacteria, and because of this, its use is typically reserved for severe [[nococomial]] [[pneumonia]], infections of a multi-resistant bacterial strain and the treatment of [[febrile]] [[neutropenia]]. | |||
Revision as of 17:48, 24 April 2008
|
| |||||||
| cefepime | |||||||
| |||||||
| Uses: | antibiotic drug | ||||||
| Properties: | beta-lactam | ||||||
| Hazards: | see drug interactions | ||||||
| |||||||
Cefepime is a fourth-generation cephalosporin antibiotic developed in 1994. It has more activity than third-generation cephalosporins against Gram-postive and Gram-negative bacteria, and because of this, its use is typically reserved for severe nococomial pneumonia, infections of a multi-resistant bacterial strain and the treatment of febrile neutropenia.